盈康生命(300143.SZ)擬將其對長沙盈康享有的600萬元借款本金及全部利息的債權轉讓給盈康醫投
格隆匯 3 月 2日丨盈康生命(300143.SZ)公佈,鑑於公司全資子公司星瑪康醫療科技(成都)有限公司(“星瑪康”)擬向公司控股股東青島盈康醫療投資有限公司(“盈康醫投”)轉讓其持有的長沙盈康醫院有限公司(“長沙盈康”)100%股權並簽訂《股權轉讓協議》,且公司根據其與長沙盈康簽訂的《借款協議》合計向長沙盈康提供了本金金額為人民幣600萬元的借款,為避免長沙盈康股權轉讓完成交割後出現關聯方資金佔用的情形,切實維護上市公司及全體股東利益,公司與盈康醫投於2021年3月1日簽訂了《債權轉讓協議》,約定公司將其對長沙盈康享有的人民幣600萬元借款本金及全部利息的債權於股權轉讓交割日同日轉讓給盈康醫投。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.